Cargando…

COVID-19 epidemic phases and morbidity in different areas of Chinese mainland, 2020

BACKGROUND: In the early stage of COVID-19 epidemic, the Chinese mainland once effectively controlled the epidemic, but COVID-19 eventually spread faster and faster in the world. The purpose of this study is to clarify the differences in the epidemic data of COVID-19 in different areas and phases in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuehai, Yu, Jinghong, Wang, Fei, Zhang, Yuqiang, Ma, Shengjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117903/
https://www.ncbi.nlm.nih.gov/pubmed/37089485
http://dx.doi.org/10.3389/fpubh.2023.1151038
_version_ 1785028693721088000
author Wang, Yuehai
Yu, Jinghong
Wang, Fei
Zhang, Yuqiang
Ma, Shengjun
author_facet Wang, Yuehai
Yu, Jinghong
Wang, Fei
Zhang, Yuqiang
Ma, Shengjun
author_sort Wang, Yuehai
collection PubMed
description BACKGROUND: In the early stage of COVID-19 epidemic, the Chinese mainland once effectively controlled the epidemic, but COVID-19 eventually spread faster and faster in the world. The purpose of this study is to clarify the differences in the epidemic data of COVID-19 in different areas and phases in Chinese mainland in 2020, and to analyze the possible factors affecting the occurrence and development of the epidemic. METHODS: We divided the Chinese mainland into areas I, I and III, and divided the epidemic process into phases I to IV: limited cases, accelerated increase, decelerated increase and containment phases. We also combined phases II and III as outbreak phase. The epidemic data included the duration of different phases, the numbers of confirmed cases, asymptomatic infections, and the proportion of imported cases from abroad. RESULTS: In area I, II and III, only area I has a Phase I, and the Phase II and III of area I are longer. In Phase IV, there is a 17-day case clearing period in area I, while that in area II and III are 2 and 0 days, respectively. In phase III or the whole outbreak phase, the average daily increase of confirmed cases in area I was higher than that in areas II and III (P = 0.009 and P = 0.001 in phase III; P = 0.034 and P = 0.002 in the whole outbreak phase), and the average daily in-hospital cases were most in area I and least in area III (P = 0.000, P = 0.000, and P = 0.000 in phase III; P = 0.000, P = 0.000, and P = 0.009 in the whole outbreak phase). The average number of daily in-hospital COVID-19 cases in phase III was more than that in phase II in each area (P = 0.000, P = 0.000, and P = 0.001). In phase IV, from March 18, 2020 to January 1, 2021, the increase of confirmed cases in area III was higher than areas I and II (both P = 0.000), and the imported cases from abroad in Chinese mainland accounted for more than 55–61%. From June 16 to July 2, 2020, the number of new asymptomatic infections in area III was higher than that in area II (P = 0.000), while there was zero in area I. From July 3, 2020 to January 1, 2021, the increased COVID-19 cases in area III were 3534, while only 14 and 0, respectively, in areas I and II. CONCLUSIONS: The worst epidemic areas in Chinese mainland before March 18, 2020 and after June 15, 2020 were area I and area III, respectively, and area III had become the main battlefield for Chinese mainland to fight against imported epidemic since March 18, 2020. In Wuhan, human COVID-19 infection might occur before December 8, 2019, while the outbreak might occur before January 16 or even 10, 2020. Insufficient understanding of COVID-19 hindered the implementation of early effective isolation measures, leading to COVID-19 outbreak in Wuhan, and strict isolation measures were effective in controlling the epidemic. The import of foreign COVID-19 cases has made it difficult to control the epidemic of area III. When humans are once again faced with potentially infectious new diseases, it is appropriate to first and foremost take strict quarantine measures as soon as possible, and mutual cooperation between regions should be explored to combat the epidemic.
format Online
Article
Text
id pubmed-10117903
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101179032023-04-21 COVID-19 epidemic phases and morbidity in different areas of Chinese mainland, 2020 Wang, Yuehai Yu, Jinghong Wang, Fei Zhang, Yuqiang Ma, Shengjun Front Public Health Public Health BACKGROUND: In the early stage of COVID-19 epidemic, the Chinese mainland once effectively controlled the epidemic, but COVID-19 eventually spread faster and faster in the world. The purpose of this study is to clarify the differences in the epidemic data of COVID-19 in different areas and phases in Chinese mainland in 2020, and to analyze the possible factors affecting the occurrence and development of the epidemic. METHODS: We divided the Chinese mainland into areas I, I and III, and divided the epidemic process into phases I to IV: limited cases, accelerated increase, decelerated increase and containment phases. We also combined phases II and III as outbreak phase. The epidemic data included the duration of different phases, the numbers of confirmed cases, asymptomatic infections, and the proportion of imported cases from abroad. RESULTS: In area I, II and III, only area I has a Phase I, and the Phase II and III of area I are longer. In Phase IV, there is a 17-day case clearing period in area I, while that in area II and III are 2 and 0 days, respectively. In phase III or the whole outbreak phase, the average daily increase of confirmed cases in area I was higher than that in areas II and III (P = 0.009 and P = 0.001 in phase III; P = 0.034 and P = 0.002 in the whole outbreak phase), and the average daily in-hospital cases were most in area I and least in area III (P = 0.000, P = 0.000, and P = 0.000 in phase III; P = 0.000, P = 0.000, and P = 0.009 in the whole outbreak phase). The average number of daily in-hospital COVID-19 cases in phase III was more than that in phase II in each area (P = 0.000, P = 0.000, and P = 0.001). In phase IV, from March 18, 2020 to January 1, 2021, the increase of confirmed cases in area III was higher than areas I and II (both P = 0.000), and the imported cases from abroad in Chinese mainland accounted for more than 55–61%. From June 16 to July 2, 2020, the number of new asymptomatic infections in area III was higher than that in area II (P = 0.000), while there was zero in area I. From July 3, 2020 to January 1, 2021, the increased COVID-19 cases in area III were 3534, while only 14 and 0, respectively, in areas I and II. CONCLUSIONS: The worst epidemic areas in Chinese mainland before March 18, 2020 and after June 15, 2020 were area I and area III, respectively, and area III had become the main battlefield for Chinese mainland to fight against imported epidemic since March 18, 2020. In Wuhan, human COVID-19 infection might occur before December 8, 2019, while the outbreak might occur before January 16 or even 10, 2020. Insufficient understanding of COVID-19 hindered the implementation of early effective isolation measures, leading to COVID-19 outbreak in Wuhan, and strict isolation measures were effective in controlling the epidemic. The import of foreign COVID-19 cases has made it difficult to control the epidemic of area III. When humans are once again faced with potentially infectious new diseases, it is appropriate to first and foremost take strict quarantine measures as soon as possible, and mutual cooperation between regions should be explored to combat the epidemic. Frontiers Media S.A. 2023-04-06 /pmc/articles/PMC10117903/ /pubmed/37089485 http://dx.doi.org/10.3389/fpubh.2023.1151038 Text en Copyright © 2023 Wang, Yu, Wang, Zhang and Ma. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Wang, Yuehai
Yu, Jinghong
Wang, Fei
Zhang, Yuqiang
Ma, Shengjun
COVID-19 epidemic phases and morbidity in different areas of Chinese mainland, 2020
title COVID-19 epidemic phases and morbidity in different areas of Chinese mainland, 2020
title_full COVID-19 epidemic phases and morbidity in different areas of Chinese mainland, 2020
title_fullStr COVID-19 epidemic phases and morbidity in different areas of Chinese mainland, 2020
title_full_unstemmed COVID-19 epidemic phases and morbidity in different areas of Chinese mainland, 2020
title_short COVID-19 epidemic phases and morbidity in different areas of Chinese mainland, 2020
title_sort covid-19 epidemic phases and morbidity in different areas of chinese mainland, 2020
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117903/
https://www.ncbi.nlm.nih.gov/pubmed/37089485
http://dx.doi.org/10.3389/fpubh.2023.1151038
work_keys_str_mv AT wangyuehai covid19epidemicphasesandmorbidityindifferentareasofchinesemainland2020
AT yujinghong covid19epidemicphasesandmorbidityindifferentareasofchinesemainland2020
AT wangfei covid19epidemicphasesandmorbidityindifferentareasofchinesemainland2020
AT zhangyuqiang covid19epidemicphasesandmorbidityindifferentareasofchinesemainland2020
AT mashengjun covid19epidemicphasesandmorbidityindifferentareasofchinesemainland2020